SBCNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as SBCWW

SBC Medical Group Holdings Inc

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$5.36+0.20 (+3.88%)

Close on Oct 19, 2026

Market cap: $549.81M
P/E (TTM): 11.4
Dividend yield: –

SBC Medical Group Holdings Inc cash flow statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Depreciation & Amortization	2.68	3.80	12
Stock-Based Compensation	0	13	–
Deferred Income Taxes	5.33	-14	4.11
Change in Inventory	-0.17	1.12	-1.83
Change in Accounts Payable	2.68	-9.59	12
Operating Cash Flow	25	21	51
Capital Expenditures	-1.40	-2.56	-8.54
Sale of Property, Plant & Equipment	7.48	0	8.05
Purchase of Investments	-20	0	-2.11
Sale & Maturity of Investments	–	–	4.13
Investing Cash Flow	-21	-10	1.79
Share Repurchases	-5.00	0	–
Stock Issued	–	–	0.00
Financing Cash Flow	38	23	6.14
Foreign Exchange Rate Adjustments	-3.26	-11	-7.31
Net Change in Cash	39	22	51
Free Cash Flow	23	18	42
Income Taxes Paid	37	30	18
Interest Paid	0.16	0.03	0.05

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 71.9%
Operating margin: 37.3%
Net margin: 28.0%
Return on equity, FY2025: 23.0%

Financial strength

Current ratio: 3.31
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 234.9%

Valuation

P/E ratio: 11.4
Price to sales: 3.14
Price to book: 2.08
Dividend yield: –